Giving priority to preclinical pain measures resistant to existing drugs for developing innovative analgesics.
- Published in:
- Drug Development Research, 2018, v. 79, n. 4, p. 147, doi. 10.1002/ddr.21429
- By:
- Publication type:
- Article
Works matching IS 02724391 AND DT 2018 AND VI 79 AND IP 4
Results: 7
1
2
In silico and in vivo investigation of ferrocene‐incorporated acyl ureas and homoleptic cadmium carboxylate derivatives for anticonvulsant, anxiolytic, and sedative potential.
- Published in:
- Drug Development Research, 2018, v. 79, n. 4, p. 184, doi. 10.1002/ddr.21435
- By:
- Publication type:
- Article
3
Evaluation of oral pharmacokinetics, in vitro metabolism, blood partitioning and plasma protein binding of novel antidiabetic agent, S009‐0629 in rats.
- Published in:
- Drug Development Research, 2018, v. 79, n. 4, p. 173, doi. 10.1002/ddr.21433
- By:
- Publication type:
- Article
4
Anti‐inflammatory and antinociceptive effects of tilifodiolide, isolated from Salvia tiliifolia Vahl (Lamiaceae).
- Published in:
- Drug Development Research, 2018, v. 79, n. 4, p. 165, doi. 10.1002/ddr.21432
- By:
- Publication type:
- Article
5
Analgesic and anti‐inflammatory activities of epicatechin gallate from Bauhinia hookeri.
- Published in:
- Drug Development Research, 2018, v. 79, n. 4, p. 157, doi. 10.1002/ddr.21430
- By:
- Publication type:
- Article
6
Issue Information – TOC.
- Published in:
- 2018
- Publication type:
- Table of Contents
7
Cover Image, Volume 79, Issue 4.
- Published in:
- Drug Development Research, 2018, v. 79, n. 4, p. i, doi. 10.1002/ddr.21361
- Publication type:
- Article